22nd Century Group, Inc. (NYSE MKT: XXII)
announced today that Joseph Pandolfino, Founder and CEO of 22nd Century
Group will be the featured guest, along with other members of
management, on Tuesday, September 30th at 11:00 AM (EDT), for the latest
installation of the Wells Fargo Securities “Tobacco Talk”
conference-call series.
Designed to provide the investment community with access to some of the
top experts in the tobacco industry, the hour-long conference call is
expected to reach hundreds of participants from the media, investment
sector, and tobacco industry. Wells Fargo Managing Director and Senior
Tobacco Analyst, Bonnie Herzog, will moderate the talk. Interested
parties are invited to dial-in to join the call; (888) 713-4382 for
domestic callers or (706) 679-1220 for international callers. The
passcode is 97448081.
The session will be a question and answer format discussing (i) the
Company’s development initiatives around consumer-acceptable potential
modified risk (reduced risk) tobacco products, (ii) the significance of
22nd Century becoming a signatory of the U.S. tobacco Master Settlement
Agreement (MSA), through its acquisition of NASCO Products, LLC,
relating to the Company’s super-premium commercial brands, (iii) 22nd
Century’s joint venture opportunities, and (iv) other topics.
Joseph Pandolfino stated, “We believe 22nd Century’s achievements in
biotechnology may ultimately facilitate a paradigm shift in the tobacco
industry. We are thrilled to have the opportunity – through the Wells
Fargo Tobacco Talk – to highlight for the investment community
how our proprietary technology enables compelling reduced-risk product
strategies.”
Separately, 22nd Century announced that the Company has launched a new
corporate website, www.xxiicentury.com,
to showcase its proprietary technology and highly differentiated
products. In addition to featuring the one-of-a-kind tobacco products
made possible by the Company’s 129 issued patents, the new website
highlights that 22nd Century has entered the cannabis industry through
investment and licensing deals with Anandia Laboratories Inc. of
Vancouver, Canada. As previously reported, and as explained on the 22nd
Century website, the Company’s entry into the cannabis space makes 22nd
Century the first and only publicly-traded company focused on both
tobacco and cannabis.
About 22nd Century Group, Inc.
22nd Century is a plant biotechnology company whose proprietary
technology through genetic engineering and plant breeding allows (i) the
level of nicotine (and other nicotinic alkaloids) in the tobacco plant
to be decreased or increased and (ii) the levels of cannabinoids to be
decreased or increased, in addition to the cannabinoid profile being
tailored. 22nd Century owns or is the exclusive licensee of 129 issued
patents in 78 countries plus an additional 51 pending patent
applications, and 22nd Century has co-exclusive rights to another 16
patent applications. Goodrich Tobacco is focused on commercial tobacco
products and potential less harmful cigarettes. Botanical Genetics is
focused on novel, cannabis plant varieties and cannabis-based products
for human health, well-being and nutrition, in addition to industrial
products refined from cannabis. Hercules Pharmaceuticals is focused on
X-22, a prescription smoking cessation aid in development.
For additional information, please visit: www.xxiicentury.com
Cautionary Note Regarding Forward-Looking Statements: This press
release contains forward-looking information, including all statements
that are not statements of historical fact regarding the intent, belief
or current expectations of 22nd Century Group, Inc., its directors or
its officers with respect to the contents of this press release. The
words “may,” “would,” “will,” “expect,” “estimate,” “anticipate,”
“believe,” “intend” and similar expressions and variations thereof are
intended to identify forward-looking statements. We cannot guarantee
future results, levels of activity or performance. You should not place
undue reliance on these forward-looking statements, which speak only as
of the date that they were made. These cautionary statements should be
considered with any written or oral forward-looking statements that we
may issue in the future. Except as required by applicable law, including
the securities laws of the United States, we do not intend to update any
of the forward-looking statements to conform these statements to reflect
actual results, later events or circumstances, or to reflect the
occurrence of unanticipated events. You should carefully review and
consider the various disclosures made by us in our annual report on Form
10-K for the fiscal year ended December 31, 2013, filed on January 30,
2014, including the section entitled “Risk Factors,” and our other
reports filed with the U.S. Securities and Exchange Commission which
attempt to advise interested parties of the risks and factors that may
affect our business, financial condition, results of operation and cash
flows. If one or more of these risks or uncertainties materialize, or if
the underlying assumptions prove incorrect, our actual results may vary
materially from those expected or projected.
Copyright Business Wire 2014